FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carlos Zala

Research Profile

Disorders

Chemicals & Drugs

Procedures

Living Beings

HIV-1

Physiology

Co-author Network

Publications

TOP 3
Ana Ceballos; Guadalupe Andreani; Chiara Ripamonti; Dario A Dilernia; Ramiro Mendez; Roberto D Rabinovich; Patricia Coll Cárdenas; Carlos Zala; Pedro Cahn; Gabriella Scarlatti; Liliana Martínez Peralta
Lack of viral selection in human immunodeficiency virus type 1 mother-to-child transmission with primary infection during late pregnancy and/or breastfeeding.
Alejandro Krolewiecki; Carlos Zala; Claudia Vanzulli; Héctor Pérez; María del Carmen Iannella; Maria B Bouzas; Ana Gun; José Valiente; Isabel Cassetti; Pedro Cahn
Safe treatment interruptions in patients with nadir CD4 counts of more than 350 cells/microL: a randomized trial.
Paula Braitstein; Carlos Zala; Benita Yip; Martin W G Brinkhof; David Moore; Hogg Robert; Julio S G Montaner
Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carlos Zala (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Ana Ceballos; Guadalupe Andreani; Chiara Ripamonti; Dario A Dilernia; Ramiro Mendez; Roberto D Rabinovich; Patricia Coll Cárdenas; Carlos Zala; Pedro Cahn; Gabriella Scarlatti; Liliana Martínez Peralta
Lack of viral selection in human immunodeficiency virus type 1 mother-to-child transmission with primary infection during late pregnancy and/or breastfeeding.
The Journal of general virology 2008;89(Pt 11):2773-82.
2006: Alejandro Krolewiecki; Carlos Zala; Claudia Vanzulli; Héctor Pérez; María del Carmen Iannella; Maria B Bouzas; Ana Gun; José Valiente; Isabel Cassetti; Pedro Cahn
Safe treatment interruptions in patients with nadir CD4 counts of more than 350 cells/microL: a randomized trial.
Journal of acquired immune deficiency syndromes (1999) 2006;41(4):425-9.
2006: Paula Braitstein; Carlos Zala; Benita Yip; Martin W G Brinkhof; David Moore; Hogg Robert; Julio S G Montaner
Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
The Journal of infectious diseases 2006;193(2):259-68.
2005: Carlos Zala; Christopher S Alexander; Claudia Ochoa; Silvia Guillemi; Lillian S L Ting; Simon Bonner; Pedro Cahn; P Richard Harrigan; Julio S G Montaner
Comparable pharmacokinetics of generic indinavir (Inhibisam) versus brand indinavir (Crixivan) when boosted with ritonavir.
Journal of acquired immune deficiency syndromes (1999) 2005;38(3):363-4.
2004: Silvia Sanchez Puch; Claudia Ochoa; Guadalupe Carballal; Carlos Zala; Pedro Cahn; Rosario Brunet; Horacio Salomón; Cristina Videla
Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;30(3):271-5.
2003: Julio S G Montaner; Pedro Cahn; Carlos Zala; Lidia I Casssetti; Marcelo H Losso; David B Hall; Jan Wruck; Marita McDonough; Maria Gigliotti; Patrick A Robinson
Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1.
Journal of acquired immune deficiency syndromes (1999) 2003;33(1):41-6.
2003: Gustavo H Kijak; Andrea Elena Rubio; Sandra Pampuro; Carlos Zala; Pedro Cahn; R Galli; Julio S G Montaner; Horacio Salomón
Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.
HIV medicine 2003;4(1):72-8.
2002: Carlos Zala; Marianne Harris; Claudia Ochoa; Mariel Tocci; Romina Quercia; Graciela Mittelman; Héctor Perez; Pedro Cahn; Julio S G Montaner
Venous and arterial blood lactate in HIV-infected patients.
Antiviral therapy 2002;7(4):309-10.
2002: Gustavo H Kijak; Viviana Simon; Peter Balfe; Jeroen Vanderhoeven; Sandra Pampuro; Carlos Zala; Claudia Ochoa; Pedro Cahn; Martin Markowitz; Horacio Salomon
Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.
Journal of virology 2002;76(14):7000-9.
2002: Carlos Zala; Horacio Salomon; Claudia Ochoa; Gustavo H Kijak; Andrea Federico; Héctor Perez; Julio S G Montaner; Pedro Cahn
Higher rate of toxicity with no increased efficacy when hydroxyurea is added to a regimen of stavudine plus didanosine and nevirapine in primary HIV infection.
Journal of acquired immune deficiency syndromes (1999) 2002;29(4):368-73.
2001: Gustavo H Kijak; Sandra Pampuro; María M Avila; Carlos Zala; Pedro Cahn; M A Wainberg; Horacio Salomón
Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina.
Antiviral therapy 2001;6(1):71-7.
2000: Carlos Zala; C Ochoa; Alejandro Krolewiecki; P Patterson; Pedro Cahn; R I Crawford; Julio S G Montaner
Highly active antiretroviral therapy does not protect against Kaposi's sarcoma in HIV-infected individuals.
AIDS (London, England) 2000;14(14):2217-8.
2000: Carlos Zala; Danielle Rouleau; Julio S G Montaner
Role of hydroxyurea in treatment of disease due to human immunodeficiency virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30 Suppl 2():S143-50.
2000: Julio S G Montaner; Theresa Mo; Janet Raboud; Sandra Rae; Christopher S Alexander; Carlos Zala; Danielle Rouleau; P Richard Harrigan
Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine.
The Journal of infectious diseases 2000;181(2):729-32.
1999: Dave M Forrest; Carlos Zala; Ognjenka Djurdjev; Joel Singer; Kevin J P Craib; L Lawson; James A Russell; Julio S G Montaner
Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia.
Archives of internal medicine 1999;159(7):741-7.
1999: Carlos Zala; Horacio Salomón; Pedro Cahn
Treatment of primary HIV infection: a pilot study of stavudine and didanosine plus nevirapine with or without hydroxyurea.
Antiviral therapy 1999;4 Suppl 3():95-9.
1998: Dave M Forrest; Ognjenka Djurdjev; Carlos Zala; Joel Singer; L Lawson; James A Russell; Julio S G Montaner
Validation of the modified multisystem organ failure score as a predictor of mortality in patients with AIDS-related Pneumocystis carinii pneumonia and respiratory failure.
Chest 1998;114(1):199-206.
1998: Carlos Zala; D Rouleau; Brian Conway
Is there anything left to learn? A report on the Fifth International Workshop on HIV Drug Resistance.
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 1998;9(3):172-6.
1997: Danielle Rouleau; Brian Conway; Janet Raboud; Sandra Rae; S Fransen; A Shillington; Carlos Zala; Michael V O'Shaughnessy; Julio S G Montaner
Stavudine plus lamivudine in advanced human immunodeficiency virus disease: a short-term pilot study.
The Journal of infectious diseases 1997;176(5):1156-60.
1997: Julio S G Montaner; Carlos Zala; Brian Conway; Janet Raboud; P Patenaude; Sandra Rae; Michael V O'Shaughnessy; Martin T Schechter
A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus (HIV) disease receiving chronic didanosine therapy: Canadian HIV trials network protocol 080.
The Journal of infectious diseases 1997;175(4):801-6.
1996: K M De Cock; D Churchill; A Grant; J Del Amo; Danielle Rouleau; Carlos Zala; M Harris; Anton Pozniak; Ian Williams
Summary of track B: clinical science.
AIDS (London, England) 1996;10 Suppl 3():S107-13.
1996: J S Montaner; P Phillips; Carlos Zala; Kevin J P Craib; Michael V O'Shaughnessy; Martin T Schechter
Adherence to guidelines for the prevention of HIV-related respiratory diseases.
The European respiratory journal 1996;9(11):2318-22.